Correlation Between IMAC Holdings and Galectin Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IMAC Holdings and Galectin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IMAC Holdings and Galectin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between IMAC Holdings and Galectin Therapeutics, you can compare the effects of market volatilities on IMAC Holdings and Galectin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IMAC Holdings with a short position of Galectin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of IMAC Holdings and Galectin Therapeutics.

Diversification Opportunities for IMAC Holdings and Galectin Therapeutics

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between IMAC and Galectin is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding IMAC Holdings and Galectin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galectin Therapeutics and IMAC Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on IMAC Holdings are associated (or correlated) with Galectin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galectin Therapeutics has no effect on the direction of IMAC Holdings i.e., IMAC Holdings and Galectin Therapeutics go up and down completely randomly.

Pair Corralation between IMAC Holdings and Galectin Therapeutics

Given the investment horizon of 90 days IMAC Holdings is expected to generate 2.47 times more return on investment than Galectin Therapeutics. However, IMAC Holdings is 2.47 times more volatile than Galectin Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Galectin Therapeutics is currently generating about 0.05 per unit of risk. If you would invest  169.00  in IMAC Holdings on August 26, 2024 and sell it today you would lose (61.00) from holding IMAC Holdings or give up 36.09% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

IMAC Holdings  vs.  Galectin Therapeutics

 Performance 
       Timeline  
IMAC Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days IMAC Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Galectin Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Galectin Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating essential indicators, Galectin Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

IMAC Holdings and Galectin Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IMAC Holdings and Galectin Therapeutics

The main advantage of trading using opposite IMAC Holdings and Galectin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IMAC Holdings position performs unexpectedly, Galectin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galectin Therapeutics will offset losses from the drop in Galectin Therapeutics' long position.
The idea behind IMAC Holdings and Galectin Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities